Results 161 to 170 of about 3,079,392 (308)
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
Pericoronary adipose tissue imaging: quantitative assessment, artificial intelligence integration, and therapeutic modulation. [PDF]
Eveson L, Sobirov I, Chan K.
europepmc +1 more source
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Transforming Growth Factor-β1 Drives Neutrophil Chemokinesis, Not Chemotaxis
Louise E Crowley,1,2 Ellen Jenkins,1 Kirsty C McGee,1,3 Theodore S Smith,1 Jon Hazeldine,1 Robert A Stockley,1 David R Thickett,1– 3 Dhruv Parekh,1– 3,* Aaron Scott1,31Department of Inflammation and Ageing, School of Infection, Inflammation and ...
Crowley LE +8 more
doaj
Epigenetic Inflammation Supports Tumorigenesis: Activator Protein 1 Drives Stem Cell Memory to Augment Colitis and Cancer. [PDF]
Wu L, Chen J, Zhang H, Wu M.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

